Krissie Lenting

627 total citations
9 papers, 468 citations indexed

About

Krissie Lenting is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Krissie Lenting has authored 9 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Krissie Lenting's work include Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (2 papers). Krissie Lenting is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (2 papers). Krissie Lenting collaborates with scholars based in Netherlands, United States and Germany. Krissie Lenting's co-authors include William P. J. Leenders, Mark ter Laan, Pieter Wesseling, Roel G.W. Verhaak, Remco J. Molenaar, Cornelis J.F. Van Noorden, Mohammed Khurshed, Sanne A. M. van Lith, Dennis Botman and Jaroslaw P. Maciejewski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Krissie Lenting

9 papers receiving 468 citations

Peers

Krissie Lenting

GENET

MB

CR

ONCOL

BE

Jianyi Ding United States

Manabu Onishi Japan

Kirsten Ludwig United States

Hayley Ellis United Kingdom

Perrine Dahan France

Aayushi Mahajan United States

Tina Zheng United States

Uroš Rajčević Slovenia

Charlotte Aaberg-Jessen Denmark

Anna C. Navis Netherlands

Jianyi Ding United States

Krissie Lenting

254 ×1.0

GENET

258 ×1.1

MB

185 ×0.9

CR

49 ×0.8

ONCOL

41 ×0.7

BE

Citations per year, relative to Krissie Lenting Krissie Lenting (= 1×) peers Jianyi Ding

Countries citing papers authored by Krissie Lenting

Since Specialization

Citations

This map shows the geographic impact of Krissie Lenting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krissie Lenting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krissie Lenting more than expected).

Fields of papers citing papers by Krissie Lenting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krissie Lenting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krissie Lenting. The network helps show where Krissie Lenting may publish in the future.

Co-authorship network of co-authors of Krissie Lenting

This figure shows the co-authorship network connecting the top 25 collaborators of Krissie Lenting. A scholar is included among the top collaborators of Krissie Lenting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krissie Lenting. Krissie Lenting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Lenting, Krissie, Remco C. de Boer, Elizabeth A. Tindall, et al.. (2019). Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Acta Neuropathologica Communications. 7(1). 185–185. 6 indexed citations

2.

Lenting, Krissie, Sanne A. M. van Lith, Remco J. Molenaar, et al.. (2019). Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate. SHILAP Revista de lepidopterología. 7(1). 4–4. 22 indexed citations

3.

Kobus, Thiele, et al.. (2019). Imaging Hyperpolarized Pyruvate and Lactate after Blood–Brain Barrier Disruption with Focused Ultrasound. ACS Chemical Neuroscience. 10(5). 2591–2601. 10 indexed citations

4.

Lenting, Krissie, Mohammed Khurshed, Sanne A. M. van Lith, et al.. (2018). Isocitrate dehydrogenase 1–mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress. The FASEB Journal. 33(1). 557–571. 34 indexed citations

5.

Lenting, Krissie, Roel G.W. Verhaak, Mark ter Laan, Pieter Wesseling, & William P. J. Leenders. (2017). Glioma: experimental models and reality. Acta Neuropathologica. 133(2). 263–282. 212 indexed citations

6.

Khurshed, Mohammed, Krissie Lenting, Remco J. Molenaar, William P. J. Leenders, & Cornelis J.F. Van Noorden. (2017). Abstract 431: IDH1-mutated gliomas rely on anaplerosis of glutamate and lactate whereas IDH1 wild-type gliomas rely on glycolysis and acetate anaplerosis. Cancer Research. 77(13_Supplement). 431–431. 1 indexed citations

7.

Khurshed, Mohammed, Remco J. Molenaar, Krissie Lenting, William P. J. Leenders, & Cornelis J.F. Van Noorden. (2017). In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma. Oncotarget. 8(30). 49165–49177. 56 indexed citations

8.

Lith, Sanne A. M. van, Anna C. Navis, Krissie Lenting, et al.. (2016). Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma. Scientific Reports. 6(1). 30486–30486. 11 indexed citations

9.

Molenaar, Remco J., Dennis Botman, Vashendriya V.V. Hira, et al.. (2015). Radioprotection of IDH1 -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. Cancer Research. 75(22). 4790–4802. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact